gemcitabine + rituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for gemcitabine + rituximab, covering 2021-11-19 to 2021-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant [Phase 3]